Aller au contenu principal
Accès ouvert déclaré 2026 article

CHRONIC POSTOPERATIVE HYPOPARATHYROIDISM DECOMPENSATED BY A RELAPSE OF THYROTOXICOSIS AND COVID-19: A CASE REPORT

0Citations signalées, ce qui n’est pas une note de qualité
4Institutions déclarées
3Pays d’affiliation déclarés

Rattachement africain : kz, us, ru. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Relevance. Chronic postoperative hypoparathyroidism is a rare complication of thyroidectomy. It needs lifelong therapy. But reports of decompensation caused by a combination of thyrotoxicosis, COVID-19, and long-term use of outdated drugs like dihydrotachysterol are few. Objective. To describe a case of decompensated chronic postoperative hypoparathyroidism in a patient with Graves' disease - and to analyse what led to the decompensation, how we diagnosed it, and how we treated it. Clinical Case. A 58-year-old woman presented in November 2023 with limb cramps, tachycardia, and tremor. She had a history of subtotal thyroidectomy for Graves' disease (1991), followed by hypoparathyroidism treated with dihydrotachysterol for over 30 years - without adequate control. In 2022, she had COVID-19 pneumonia (60 % lung involvement) and then a stroke, which left her with left-sided hemiparesis. On admission: total calcium 1.57 mmol/L, ionized calcium 0.61 mmol/L, phosphorus 1.64 mmol/L, PTH 6.78 pg/mL, plus decompensated thyrotoxicosis (free T4 29.45 pmol/L, TSH receptor antibodies 13.5 IU/L), a prolonged QT interval, and a cataract. We started alfacalcidol 1 μg/day, calcium carbonate 2000 mg/day, and thiamazole 30 mg/day. Over 15 months, her calcium normalised to 2.35 mmol/L, TSH receptor antibodies fell to 4.61 IU/L, and she became euthyroid. But then she stopped alfacalcidol on her own - because she felt well - and her calcium dropped again. Conclusion. This case shows three things. First, dihydrotachysterol is outdated and should be replaced with active vitamin D metabolites. Second, COVID-19 can trigger calcium-phosphorus decompensation. Third, thorough biochemical monitoring is essential - and patients need to be warned not to stop alfacalcidol even when they feel completely well.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
CHRONIC POSTOPERATIVE HYPOPARATHYROIDISM DECOMPENSATED BY A RELAPSE OF THYROTOXICOSIS AND COVID-19: A CASE REPORT
Date Crossref
01/01/2026
Éditeur
Non-state educational institution "Kazakh-Russian Medical University"
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Thyroid and Parathyroid SurgeryThyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.